Literature DB >> 5938857

Anticoagulation for prevention of thromboembolism following fractures of the hip.

E W Salzman, W H Harris, R W DeSanctis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5938857     DOI: 10.1056/NEJM196607212750302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Fifteen-year clinical experience with the vena cava filter.

Authors:  M S DeWeese; R O Kraft; W K Nichols; H H Six; N W Thompson
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

2.  The epidemiology of lower extremity deep venous thrombosis in surgical patients.

Authors:  B Sigel; J Ipsen; W R Felix
Journal:  Ann Surg       Date:  1974-03       Impact factor: 12.969

3.  Dextran prophylaxis in surgery.

Authors:  R Brisman; L C Parks; J A Haller
Journal:  Ann Surg       Date:  1971-07       Impact factor: 12.969

Review 4.  Local and systemic factors in the pathogenesis of thrombosis.

Authors:  D Deykin
Journal:  Calif Med       Date:  1970-03

5.  The treatment of pulmonary embolism.

Authors:  R L Hackney
Journal:  J Natl Med Assoc       Date:  1971-09       Impact factor: 1.798

6.  Thromboembolism and its prevention.

Authors:  S Sevitt
Journal:  Proc R Soc Med       Date:  1968-02

7.  Prophylaxis of pulmonary embolism.

Authors:  N L Browse
Journal:  Br Med J       Date:  1970-06-27

8.  Heparin prophylaxis for deep vein thrombosis and pulmonary embolism.

Authors:  C Olcott
Journal:  West J Med       Date:  1976-09

Review 9.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 10.  Safety of treatment with oral anticoagulants in the elderly. A systematic review.

Authors:  B A Hutten; A W Lensing; R A Kraaijenhagen; M H Prins
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.